12:00 AM
Mar 27, 2000
 |  BC Week In Review  |  Company News  |  Deals

Abgenix, Corixa Inc. deal

The companies will develop human monoclonal antibodies against targets from CRXA's library of autoimmune, cancer and infectious diseases antigens. CRXA will supply three to...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >